|
Pronunciation |
|
(heks
a KLOR oh
feen) |
|
|
U.S. Brand
Names |
|
pHisoHex®;
Septisol® |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Antibacterial, Topical |
|
|
Use |
|
Surgical scrub and as a bacteriostatic skin cleanser; control an outbreak of
gram-positive infection when other procedures have been
unsuccessful |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Known hypersensitivity to halogenated phenol derivatives or hexachlorophene;
use in premature infants; use on burned or denuded skin; occlusive dressing;
application to mucous membranes |
|
|
Warnings/Precautions |
|
Discontinue use if signs of cerebral irritability occur; exposure of preterm
infants or patients with extensive burns has been associated with apnea,
convulsions, agitation and coma; do not use for bathing infants, premature
infants are particularly susceptible to hexachlorophene topical
absorption |
|
|
Adverse
Reactions |
|
<1%: CNS injury, seizures, irritability, photosensitivity, dermatitis,
redness, dry skin |
|
|
Overdosage/Toxicology |
|
Symptoms of overdose include anorexia, vomiting, abdominal cramps, diarrhea,
dehydration, seizures, hypotension, shock
Treatment is supportive |
|
|
Drug
Interactions |
|
No data reported |
|
|
Stability |
|
Store in nonmetallic container ( incompatible with many metals);
prolonged direct exposure to strong light may cause brownish surface
discoloration, but this does not affect its action |
|
|
Mechanism of
Action |
|
Bacteriostatic polychlorinated biphenyl which inhibits membrane-bound enzymes
and disrupts the cell membrane |
|
|
Pharmacodynamics/Kinetics |
|
Absorption: Percutaneously through inflamed, excoriated, and intact skin
Distribution: Crosses the placenta
Half-life: Infants: 6.1-44.2 hours |
|
|
Usual Dosage |
|
Children and Adults: Topical: Apply 5 mL cleanser and water to area to be
cleansed; lather and rinse thoroughly under running water |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Do not leave on skin for prolonged contact; for external use only;
discontinue product if condition persists or worsens and call physician; if suds
enter eye, rinse out thoroughly with water |
|
|
Nursing
Implications |
|
Do not use for bathing infants; premature infants are particularly
susceptible to hexachlorophene topical absorption |
|
|
Dosage Forms |
|
Foam (Septisol®): 0.23% with alcohol 56% (180 mL, 600
mL)
Liquid, topical (pHisoHex®): 3% (8 mL, 150 mL, 500 mL,
3840 mL) |
|
|
References |
|
Halling H,
"Suspected Link Between Exposure to Hexachlorophene and Malformed Infants,"
Ann N Y Acad Sci, 1979, 320:426-35.
Lester RS, "Topical Formulary for the Pediatrician," Pediatr Clin North
Am, 1983, 30(4):749-65.
Lockhart JD, "How Toxic is Hexachlorophene?" Pediatrics, 1972,
50(2):229-35.
Marquardt ED, "Hexachlorophene Toxicity in a Pediatric Burn Patient," Drug
Intell Clin Pharm, 1986, 20(7-8):624.
Nagy L and Orosz M, "Occupational Asthma Due to Hexachlorophene,"
Thorax, 1984, 39(8):630-1. |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|